Showing 36,902 results

Harm reduction

More Syringe Exchanges Can Open in New Jersey, Thanks to a New Law

Editor's pick
POZ
25 January 2022
The search for a cure

Early research suggests cancer drug could help flush HIV from its hiding spots

Editor's pick
STAT
27 January 2022
Pharmaceutical industry

CytoDyn board ousts CEO after a wild year, leaving an albatross of a C-suite job to fill

Editor's pick
FierceBiotech
27 January 2022
Sex workers

Men who paid for sex more likely than other men to live with HIV

Editor's pick
EurekAlert
27 January 2022
New & experimental HIV treatments

Antiviral Efficacy, Safety, Tolerability of a Novel HIV-1 Maturation Inhibitor (GSK'254)

Editor's pick
Infectious Disease Advisor
31 January 2022
Drug policy & policing

Model that Decriminalized Drugs, Invests Savings Shows Reduction in HIV Transmission

Editor's pick
Contagion Live
31 January 2022
Migrants, refugees & displaced people

Migration impacts treatment access for women in South Sudan who sell sex

Editor's pick
Avert
31 January 2022
The search for an HIV prevention vaccine

HIV mRNA Vaccine Trial Is Now Underway

Editor's pick
POZ
31 January 2022
Sexually transmitted infections epidemiology

UK: Drug-Resistant Shigella Surges Among Gay and Bisexual Men

Editor's pick
Medscape (requires free registration)
31 January 2022
HIV & criminal law

New Jersey Repeals Outdated HIV Crime Laws and Fights Stigma

Editor's pick
POZ
1 February 2022
Health problems in children & young people

Fatty Liver Disease Is Common Among Young People Living With HIV

Editor's pick
POZ
1 February 2022
Injectable & long-acting HIV treatment

ViiV Healthcare announces US FDA approval of Cabenuva (cabotegravir, rilpivirine) for use every two months, expanding the label of the first and only complete long-acting HIV treatment

Editor's pick
ViiV press release
1 February 2022
Treatment outcomes & life expectancy

Improvements in survival for people with HIV continue to be achieved

Editor's pick
CATIE
2 February 2022
Cancer

French researchers investigate second cancers in people with HIV who survived a first cancer

Editor's pick
CATIE
2 February 2022
Harm reduction

It’s Time for Maine to Free Us From One-to-One Syringe Distribution

Editor's pick
Filter
2 February 2022
Global health initiatives

Governments are 'trying to muzzle WHO,' says HIV activist

Editor's pick
Devex
2 February 2022
Experiences of stigma

HIV Stigma Persists Globally, According to Harris Poll

Editor's pick
Medscape (requires free registration)
2 February 2022
Pharmaceutical industry

GSK to get $1.25 bln to settle HIV drug patent row with Gilead

Editor's pick
Reuters
2 February 2022
PrEP policies & guidelines

When you're charged a PrEP copay you shouldn't owe

Editor's pick
Axios
2 February 2022
How HIV works

A 'highly virulent' HIV strain is 'no cause for alarm,' scientists say

Editor's pick
NBC News
4 February 2022
How HIV works

Why You Don’t Need to Worry About the Newly Identified “Highly Virulent” Strain of HIV

Editor's pick
POZ
7 February 2022
Pharmaceutical industry

Deborah Waterhouse: ‘The HIV stigma remains, and this is a battle we’ve got to fight’

Editor's pick
The Guardian
7 February 2022
The search for an HIV prevention vaccine

Analysis: Moderna's HIV Vaccine Trial Will Advance Many Companies' mRNA Plans

Editor's pick
The Washington Post
7 February 2022
Epidemiology

Men who pay for sex: a missing at-risk population?

Editor's pick
Avert
7 February 2022